The grant program is designed to assist providers in expanding or strengthening the services they offer to patients.

As the year opens up, many of us living with sickle cell disease find ourselves in a reflective space. Gratitude at the beginning of the year is not simply a list of blessings; for people living with ...

Emmaus has granted NeoImmuneTech Inc. an exclusive license to all rights to market, sell and distribute Endari and any ...

Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...

Beam Therapeutics Inc. (NASDAQ: BEAM) is among the 12 Best Genomics Stocks to Invest In.

Mariela Fonseca Ruiz selected a story about James Griffin, a local man raising awareness about sickle cell disease, as a memorable story of 2025.

Emmaus Life Sciences, Inc. (OTCQB: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that it has entered into a License and ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Mary Thomson and her husband, Kanjala, have lost their income amid changing witchdoctors, but their firstborn’s suffering has not changed. Since 2011, Ethel, 15, was frequently bedridden with severe ...

The fight against sickle cell has got impetus after an organisation started an initiative for reducing infant mortalities.

Family, neighbors and close friends gathered for a candlelight vigil to remember 23-year-old Jamar Jordan Gray, who died Dec.